Hepion Pharmaceuticals HEPA Stock
Hepion Pharmaceuticals Price Chart
Hepion Pharmaceuticals HEPA Financial and Trading Overview
| Hepion Pharmaceuticals stock price | 0.12 USD |
| Previous Close | 0.09 USD |
| Open | 0.11 USD |
| Bid | 0.11 USD x 2723500 |
| Ask | 0.11 USD x 773000 |
| Day's Range | 0.11 - 0.11 USD |
| 52 Week Range | 0.03 - 0.12 USD |
| Volume | 8.75K USD |
| Avg. Volume | 39.76K USD |
| Market Cap | 10.31M USD |
| Beta (5Y Monthly) | 1.751 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.19 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
HEPA Valuation Measures
| Enterprise Value | 9.09M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.009186351 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Hepion Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.751 |
| 52-Week Change | 53.84% |
| S&P500 52-Week Change | 15.77% |
| 52 Week High | 0.12 USD |
| 52 Week Low | 0.03 USD |
| 50-Day Moving Average | 0.07 USD |
| 200-Day Moving Average | 0.06 USD |
HEPA Share Statistics
| Avg. Volume (3 month) | 39.76K USD |
| Avg. Daily Volume (10-Days) | 63.36K USD |
| Shares Outstanding | 98.22M |
| Float | 43.19M |
| Short Ratio | 0.05 |
| % Held by Insiders | 66.43% |
| % Held by Institutions | 0% |
| Shares Short | 448.18K |
| Short % of Float | 4.09% |
| Short % of Shares Outstanding | 4.09% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 1:50 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -61.16% |
| Return on Equity (ttm) | -125.64% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -3188419 USD |
| Diluted EPS (ttm) | -0.19 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.63M USD |
| Total Cash Per Share (mrq) | 0.02 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.912 |
| Book Value Per Share (mrq) | -0.014 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1594109 USD |
| Levered Free Cash Flow (ttm) | -416206 USD |
Profile of Hepion Pharmaceuticals
| Country | United States |
| State | NJ |
| City | Morristown |
| Address | 55 Madison Avenue |
| ZIP | 07960 |
| Phone | 732 902 4000 |
| Website | https://hepionpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC), metabolic liver diseases, and chronic liver diseases in the United States. It developed Rencofilstat, a therapeutic drug candidate that binds and inhibits the function of a specific class of isomerase enzymes called cyclophilins that regulates protein folding, as well as preclinical experiments of Rencofilstat reflects decreased liver fibrosis; liver inflammation; liver tumor burden; and titers of HBV, HCV, and HDV. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Morristown, New Jersey.
Q&A For Hepion Pharmaceuticals Stock
What is a current HEPA stock price?
Hepion Pharmaceuticals HEPA stock price today per share is 0.12 USD.
How to purchase Hepion Pharmaceuticals stock?
You can buy HEPA shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hepion Pharmaceuticals?
The stock symbol or ticker of Hepion Pharmaceuticals is HEPA.
Which industry does the Hepion Pharmaceuticals company belong to?
The Hepion Pharmaceuticals industry is Biotechnology.
How many shares does Hepion Pharmaceuticals have in circulation?
The max supply of Hepion Pharmaceuticals shares is 98.22M.
What is Hepion Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Hepion Pharmaceuticals PE Ratio is now.
What was Hepion Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Hepion Pharmaceuticals EPS is -0.19 USD over the trailing 12 months.
Which sector does the Hepion Pharmaceuticals company belong to?
The Hepion Pharmaceuticals sector is Healthcare.
Hepion Pharmaceuticals HEPA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
27343.41 USD — |
+0.55
|
3.63B USD — | 27254.03 USD — | 27376.85 USD — | — - | 3.63B USD — |
|
US Tech Capital Market Composite
RCMP
US
|
124.79 USD — |
+0.56
|
— — | 124.02 USD — | 125.07 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1316.81 USD — |
+2.41
|
— — | 1286.21 USD — | 1317.4 USD — | — - | — — |
- {{ link.label }} {{link}}
